Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ce |
RCV000416169 | SCV000493469 | likely benign | not provided | 2023-08-01 | criteria provided, single submitter | clinical testing | FLNC: BP4, BP7 |
Invitae | RCV001088732 | SCV000651025 | likely benign | Myofibrillar myopathy 5; Distal myopathy with posterior leg and anterior hand involvement; Hypertrophic cardiomyopathy 26; Dilated Cardiomyopathy, Dominant | 2024-01-13 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000416169 | SCV001790569 | likely benign | not provided | 2020-12-17 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002328904 | SCV002631067 | likely benign | Cardiovascular phenotype | 2019-10-20 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |